靶向生物膜的局部抗生素治疗难治性医疗器械相关感染:以导线感染为模型
导线感染是心室辅助装置植入后的难治并发症,生物膜形成是感染发生和复发的根源。本文基于葡萄球菌生物膜低代谢状态导致高耐药性的机制,提出假说:合理联用弱代谢依赖和强代谢依赖的高浓度抗生素并延长疗程,可能根除生物膜包括耐受菌和持留菌。若获临床验证,该策略有望实现医疗器械相关感染的长期治疗成功。
要点
- 生物膜低代谢状态是葡萄球菌高耐药的核心机制,也是潜在治疗靶点。
- 高浓度局部抗生素联合清创和/或装置再植入已有治疗成功报道。
- 联用弱代谢依赖与强代谢依赖抗生素并延长疗程可能根除生物膜。
核心结论
- 合理联用弱代谢依赖和强代谢依赖的高浓度抗生素并延长疗程,可能根除葡萄球菌生物膜包括耐受菌和持留菌。
- 若获临床验证,该策略可能实现医疗器械相关感染的长期治疗成功。
主要发现
- 葡萄球菌生物膜的低代谢状态是高抗菌耐药性的核心机制。
- 高浓度局部抗生素联合手术清创和/或装置再植入在部分病例中已有治疗成功的报道。
临床怎么用
- 对导线感染等医疗器械相关感染,可考虑高浓度局部抗生素联合手术清创和/或装置再植入。
- 可探索联用弱代谢依赖与强代谢依赖抗生素并延长疗程以根除生物膜。
局限性
- 临床经验仍然有限。
- 该策略尚未经临床验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Driveline infection, exemplifying medical device-associated infection, is a difficult-to-treat complication of ventricular assist device implantation in which biofilm formation underlies both infection onset and recurrence. Although clinical experience remains limited, treatment success has been reported in cases where local antibiotics at high concentrations were used in combination with surgical debridement and/or device reimplantation. We recently identified the low metabolic state of biofilm cells as the central mechanism underlying the high antimicrobial resistance of staphylococcal biofilms and as a potential therapeutic target for driveline infections. We hypothesize that rationally combining weakly and strongly metabolism-dependent antibiotics at high concentrations for an extended period may eradicate staphylococcal biofilms, including the embedded tolerant and persister cells. If clinically validated, this strategy may hold the key to achieving long-term treatment success in many medical device-associated infections, including the driveline infection.
引用
- Qu Y, Kaye DM, McGiffin D, et al. Using biofilm-targeting local antibiotics to treat recalcitrant medical device-associated infections: driveline infection as a model. J Antimicrob Chemother. 2026. PMID: 42262127. doi:10.1093/jac/dkag203
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。